SBFM Q3 2020 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$17,150+134.1% YoY

Gross Profit

$10,81063.0% margin

Operating Income

-$67,288-392.3% margin

Net Income

-$698,595-4073.4% margin

EPS (Diluted)

$-918.00

QoQ Revenue Growth

+13.2%

Cash Flow

Operating Cash Flow

-$120,577

Free Cash Flow

-$121,377

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$550,522

Total Liabilities

$1M

Stockholders' Equity

-$554,876

Cash & Equivalents

$488,708

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17,150	$7,326	+134.1%
Gross Profit	$10,810	$2,033	+431.7%
Operating Income	-$67,288	-$202,640	+66.8%
Net Income	-$698,595	-$350,241	-99.5%